Pregnancy outcomes in women with aortic coarctation

Figures

• 

  Figure 1. Cardiac events (top) and obstetric and fetal events (bottom) in women with aortic coarctation. Pre-existing hypertension versus no pre-existing hypertension (left) and unrepaired versus repaired (right). *P<0.05. There were no cases of ventricular tachyarrhythmia, endocarditis, thromboembolic events, acute coronary syndrome or aortic dissection. (e)CS, (emergency) caesarean section; MACE, major adverse cardiac event; PE, (pre-)eclampsia; PIH, pregnancy-induced hypertension; PPH, postpartum haemorrhage.

• 

  Figure 2. Univariate regression analysis, identifying predictors of major adverse cardiac events in pregnancy. Asterisk (*) denotes statistical significance. BMI, body mass index (kg/m2); CoA:, aortic coarctation.; HT, disorder: hypertensive disorder; LVEF, left ventricular ejection fraction; n.a., not available; NYHA, New York Heart Association.

• 

  Figure 3. Univariate regression analysis, identifying predictors of hypertensive complications in pregnancy. Asterisk (*) denotes statistical significance. BMI, body mass index (kg/m2); CoA, aortic coarctation; HT, hypertensive disorder; LVEF, left ventricular ejection fraction; n.a., not available; NYHA, New York Heart Association.

• 

  Figure 4. Summarising figure of pregnancy outcomes in women with aortic coarctation. AF, atrial fibrillation; HF, heart failure; MACE, major adverse cardiac event (defined as maternal cardiac death, heart failure, atrial fibrillation or flutter, ventricular tachyarrhythmia, endocarditis, thromboembolic events, aortic dissection and acute coronary syndrome).